• Equity PC Ratio   0.57
  • |
  • Index PC Ratio   1.14
  • |
  • Total PC Ratio   0.97
  • |
  • VIX PC Ratio   0.54
  • VIX 16.48
  • VXN 19.83
  • VXO 17.26
  • ISEE 85.00

TruCharts Trading Strategies and Stock Buy/Sell Reports
(Show Details)


Chart Settings
No saved settings found!

Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:





Indicator Windows:





YES
Refresh      
LLY (Eli Lilly and Company)
Last Trade 128.3 Dividend/Share 2.58 PE Ratio 23.08
Date March 22-2019 Dividend Yield 2.011 Return on Assets 7.31
Change -0.01 ExDividend Date 2019-02-14 Return on Capital null
Bid null Latest EPS 3.13 Price/Sale 5.071
Ask null LatestEPS Date 2018-12-31 Price to Book 12.67
Volume null EPS ttm 5.560 Institutional % 118.7
Avg Volume 24.73M Shares Outstanding 970.42M Insider % null
Open 128.5 Float 966.22M Short Ratio 4.980
Prev Close 128.31 Return On Equity 30.33 5 Year Change % 1.552
High 129.48 Consensus EPS 1.36 2 Year Change % 0.569
Low 127.43 No. of Estimate 4.000 1 Year Change % 0.667
52 Week High 130.51 EPS Surprise $ null YTD Change % 0.123
52 Week Low 74.51 EPS Surprise Percent -2.2059 6 Month Change % 0.226
52 Week Change 71.512 EBITDA 0M 3 Month Change % 0.190
50 Day MA 121.30355 Revenue 0M 1 Month Change % 0.048
200 Day MA Gross Profit 0M 5 Day Change % 0.024
Market Cap 124504.6M Cash 0M 30 Day Change % 0.079
Beta 0.333115 Debt 0M Stock Exchange New York Stock Exchange
Sector Healthcare Revenue Per Share 0 Short Interest 35274912
Short Date 2019-02-15 Revenue Per Employee 0 Short Ratio 4.980
Data courtesy of IEX
Company Profile

Eli Lilly and Company develops, manufactures, and sells pharmaceutical products worldwide. It offers neuroscience products to treat schizophrenia, manic episodes, and bipolar maintenance; depression and diabetic peripheral neuropathic pain; attention-deficit hyperactivity disorder in children, adolescents, and adults; depression, bulimia nervosa, and obsessive-compulsive disorders; and bipolar depression and treatment-resistant depression. The company?s endocrinology products are used for diabetes; type 2 diabetes; osteoporosis in postmenopausal women; osteoporosis in postmenopausal women and men at high risk for fracture; and human growth hormone deficiency and pediatric growth conditions. It also provides oncology products to treat malignant pleural mesothelioma; pancreatic, metastatic breast, non-small cell lung, ovarian, and bladder cancers; and colorectal cancers, as well as offers cardiovascular products for treating erectile dysfunction, for the reduction of thrombotic cardiovascular events in patients with acute coronary syndrome, as an adjunct to percutaneous coronary intervention, and for the treatment of adults with severe sepsis at high risk of death. In addition, the company offers animal health products, such as cattle feed additives; antibiotics used to treat respiratory diseases and other diseases in cattle, swine, and poultry; leanness and performance enhancers for swine and cattle; protein supplements to improve milk productivity in dairy cows; anticoccidial agents for use in poultry; antibiotics used to control enteric infections in calves and swine; parasiticides for use on cattle and premises; and products that prevents flea infestations on dogs, as well as other pharmaceutical products to treat staphylococcal infections and bacterial infections. Eli Lilly distributes its products principally through independent wholesale distributors, as well as directly to pharmacies. The company was founded in 1876 and is based in Indianapolis, Indiana.